This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Vreeland, B. Articles by Kim, E. Search for Related Content Social Bookmarking                         What's this?

Managing the Clinical Consequences of Psychiatric Illness and Antipsychotic Treatment: A Discussion of Obesity, Diabetes, and Hyperprolactinemia

University of Medicine and Dentistry of New Jersey (UMDNJ); UMDNJ-University Behavioral HealthCare; UMDNJ-School of Nursing; UMDNJ-Robert Wood Johnson Medical School in Piscataway, New Jerseyvreelael{at}umdnj.edu

Edward Kim

Adult Services for the University of Medicine and Dentistry of New Jersey (UMDNJ); University Behavioral HealthCare; UMDNJ-Robert Wood Johnson Medical School, in Piscataway, NJ.

Many individuals who suffer from serious and persistent mental illness also have co-occurring physical problems that are frequently misdiagnosed, underdiagnosed, or undertreated. Tragically, this population loses between 8 and 20 years of life expectancy when compared to a nonpsychiatric population. Hyperglycemia, diabetes, and weight gain have long been established as correlating with mental illness and psychotropic medications, leaving it difficult to identify which condition came first. Hyperprolactinemia is an additional consequence of select antipsychotic therapies that results in endocrine and sexual disturbances. Clinicians need to understand how to assess and manage the health risks associated with psychiatric conditions and their treatments. The psychiatric nurse is a key member of the health care team whose holistic framework can afford an opportunity to bridge the gap between mental and physical health. This article discusses the overall assessment and management of psychotropic-associated weight gain, obesity, type 2 diabetes, and hyperprolactinemia in patients with schizophrenia and bipolar disorder.

Key Words: psychotropic-associated weight gain • obesity • type 2 diabetes • hyperprolactinemia

Journal of the American Psychiatric Nurses Association, Vol. 10, No. 3 suppl, S17-S24 (2004)
DOI: 10.1177/1078390304265287


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. Simmons-Alling and S. Talley Bipolar Disorder and Weight Gain: A Multifactorial Assessment Journal of the American Psychiatric Nurses Association, January 1, 2008; 13(6): 345 - 352. [Abstract] [PDF]